UBS Initiates Coverage on Teleflex Incorporated (TFX) with Neutral

Market Context

Teleflex Incorporated operates in the Healthcare sector. The stock currently trades at $134.20 with a market capitalization of $5.6B. The stock has gained 22.5% over the past 52 weeks.

Analyst coverage from UBS provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Teleflex Incorporated.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Teleflex Incorporated

Among the 10 most recent ratings: 4 Buy, 6 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jul 28, 2026	UBS	Neutral	N/A
Jul 15, 2026	Mizuho	Neutral	N/A
Jul 09, 2026	BMO Capital	Outperform	N/A
Jun 08, 2026	Piper Sandler	Overweight	N/A
May 11, 2026	Truist Securities	Hold	N/A

Related Tools: Analyst Ratings Dashboard | View TFX Stock Page